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Abstract
Malaria caused by Plasmodium falciparum remains the most virulent form of malaria, resulting 
in 216 million cases and 445,000 deaths globally. Invasion of red blood cells by P. falciparum 
leads to the formation of membranous structures known as Maurer's clefts (MC). Virulence 
markers of P. falciparum such as PfEMP1 are transported across the MC to the surface of the 
infected red blood cell. Insight into the formation and function of the MC will be important for 
the discovery of new vaccine and drug candidates. The PfMC-2TM is encoded by a multi-gene 
family of 13 members. PfMC-2TM is a protein localized to the MC. We induced expression of 
PfMC-2TM encoded by 1 family member [PF3D7_0114100 (PFA0680c)] in BL21 DE3 strain of 
Escherichia coli following transformation with recombinant pET-28a plasmid containing a 
chemically synthesized gene. The purpose of this study was to determine immunogenic 
properties of the resulting recombinant protein using western blot analysis. The recombinant 
plasmid was isolated and analyzed in 1% agarose gel and an approximately 5kb band was 
identified. Pilot expression of transformants showed expression of recombinant PfMC-2TM by 
western blot. Recombinant PfMC-2TM protein will be expressed and purified for antibody 
production to allow subsequent domain analysis and characterization.
Introduction
□ Malaria
■ 216 million cases worldwide and 445,000 deaths worldwide (World Health 
Organization, www.who.int/)
■ Infection transmitted by female Anopheles mosquito
■ Infection caused by Plasmodium parasites (protozoans)
• P. falciparum-most virulent form
• P. ovale
• P. malariae
• P. knowlesi
• P. vivax
□ Plasmodium falciparum
■ Cause of Complicated/Severe Malaria
■ Only species that develops Maurer's clefts (MC)
• MC responsible for protein transport from red cell cytopalsm to erythrocyte 
membrane (RBCM)
■ Virulence protein PfEMP1 is associated with knobs on the surface of RBC
■ PfMC-2TM is localized to the MC
□ Rationale
■ The rationale behind this project is to determine if the full-length chemically 
synthesized gene, following bacterial transcription and subsequent translation, 
can yield a protein with immunogenic properties.
Objectives and Hypothesis
□ Objectives
■ Transform DH5a strain E.coli bacteria with full-length pET-28a(+) PfMC-2TM 
recombinant plasmid
■ Induce expression of the PfMC-2TM protein in BL21 DE3 strain of E. coli
■ Analyze bacterially synthesized protein by western blot analysis and determine 
potential immunogenicity
□ Question
■ Do E. coli transformed with chemically synthesized PfMC-2TMrecombinant pET- 
28a(+) plasmid yield an immunogenic PfMC-2TM protein?
□ Hypothesis
■ E. coli bacteria transformed with chemically synthesized PfMC-2TMrecombinant 
plasmid pET-28a(+) yield immunogenic PfMC-2TM protein
Methods
□ Transformed recombinant PfMC-2TM into E. coli strains DH5a and BL21 DE3
□ Selected 4 DH5a and 6 BL21 DE3 transformants
□ Plated transformants on LB-Kanamycin plates and LB broth
Figure 1. General Plasmodium Life Cycle. Obtained from www.cdc.gov Figure 2. pET-28a(+) plasmid map showing available restriction sites and Kanamycin resistance gene.
Figure 3. Sequence of chemically synthesized PfMC-2TM gene 
containing added restrictions sites and pET-28a(+) plasmid 
backbone.
Figure 4. Figure taken from Mundwiler-Pachlakto and Beck [1] (A) Light microscope
image from Georg Maurer's publication of Maurer's clefts. (B) Electron microscopy of 
Maurer's clefts (scale bar 500nm). Figure 5. Recombinant PfMC-2TM
pET-28a(+) plasmid isolated from
DH5a strain E. coli analyzed on 1% 
agarose gel electrophoresis. DNA 
ladder used was TrackItTM 1Kb Plus 
DNA Ladder (Invitrogen). Plasmid 
isolation was performed using the 
Qiagen Plasmid Mini Kit. The 
recombinant plasmid was 
constructed and verified by 
GenScript (Piscataway, NJ) using 
restriction enzyme analysis and 
DNA sequencing to validate insert 
location in the pET-28a plasmid 
(see plasmid map).
Figure 6. BL21 DE3 growth curves and 1mM isopropylthiol-β-D-galactoside (IPTG) induction. Optical 
density (OD) readings of bacteria broth cultures were done in triplicate and repeated twice by UV-Vis 
Spectroscopy in Fixed View settings at 600nm. Readings were taken every 30 minutes for a total of 2 
hours. Shaker/Incubator was set at a rangeof36-38oCandshakingintensity4.
Figure 7. Western blot of pilot 
expression yields immunogenic PfMC- 
2TM protein. SDS-PAGE of protein 
extracts obtained from BL21 DE3 
cultures and P. falciparum schizonts. 
The figures show nitrocellulose paper 
(NCP) containing proteins transferred 
from SDS-PAGE gels. Proteins on NCP 
were probed with rabbit-anti-PfMC-
2TM peptide antibodies (10A and 11A). 
Negative control: Normal Rabbit 
Serum (10B and 11B).
Results and Conclusions
- pET28a plasmid was isolated from DH5a E. coli cultures
- PfMC-2TM was successfully expressed in BL21-DE3 E. coli cultures 
- Full-length recombinant PfMC-2TM reacted strongly with rabbit-anti-PfMC-
2TM antibodies
Future Directions
- Repeat pilot expression to obtain more protein
- Express protein for purification
S Purified protein will be used for antibody production 
S Antibodies will be used for domain and epitope characterization
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